— Know what they know.
Not Investment Advice

CODX NASDAQ

Co-Diagnostics, Inc.
1W: -0.9% 1M: -6.9% 3M: -60.4% YTD: -80.6% 1Y: -89.8% 3Y: -96.6% 5Y: -99.6%
$1.08
+0.00 (+0.00%)
 
Weekly Expected Move ±11.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 29 · $6.8M mcap · 5M float · 74.98% daily turnover · Short 50% of daily vol

Supply Chain Overview

10 relationships
10
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-06-16
Earliest Filing
2025-10-29
Latest Filing
partner: 7 target: 2 acquirer: 1

Counterparties (Filed by CODX)

10 relationships

Companies named in CODX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Maxim Group LLC MMS partner Placement agent for the proposed placement of common stock 2025-10-29 View
Dorsey & Whitney LLP — partner Legal counsel providing opinions and negative assurance 2025-10-29 View
Tanner & Co Inc. — partner Independent registered public accounting firm providing financial letter 2025-10-29 View
Maxim Group LLC MMS partner Sales agent for the equity distribution agreement. 2025-10-20 View
Maxim Group LLC MMS partner Placement agent for the proposed placement of common stock 2025-09-18 View
Dorsey & Whitney LLP — partner Legal counsel providing opinions and negative assurance 2025-09-18 View
Tanner & Co Inc. — partner Independent registered public accounting firm 2025-09-18 View
Co-Diagnostics, Inc. CODX acquirer Parent company in the merger agreement amendment 2022-06-16 View
Advanced Conceptions, Inc. — target Surviving company in the merger agreement amendment 2022-06-16 View
ACI Merger Corp. — target Merging company in the merger agreement amendment 2022-06-16 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-25 Shareholder Vote View
2026-09-16 Other Events; Exhibits View
2026-09-16 Regulation FD; Exhibits View
2026-09-15 Other Events View
2026-09-04 Shareholder Vote View
2026-09-04 Officer/Director Change View
2026-08-13 Earnings Release; Regulation FD; Exhibits View
2026-07-31 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-07-27 Material Agreement; Exhibits Agreement View
2026-05-21 Material Agreement; Unregistered Equity Sales; Other Events; Exhibits Agreement View
2026-03-31 Earnings Release; Regulation FD; Exhibits View
2026-03-10 Results of Operations and Financial Condition; Other Events View
2026-01-13 Notice of Delisting or Transfer View
2025-12-30 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-12-05 Submission of Matters to a Vote of Security Holders View
2025-11-13 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-10-29 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-10-20 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Financial St Agreement View
2025-09-30 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-09-18 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms